Skip to content
Insider tapeFilings through Fri, Oct 9
Watchlist
SKYE

Skye Bioscience (SKYE) stock: insider trades, news & valuation

Heavy selling
Close · Oct 9, 2026 $1.69 +0.6% on the day -87.7% over 12 months 52-week range $1.57 – $13.84

Share price and insider trades

SKYE closeInsider buyInsider sale
051015NovDecJan 2026FebMarAprMayJunJulAugSepOctSold $4,928 on 2026-08-20 · 5Am Partners Ii, Llc, Andrew J. SchwabSold $47,698 on 2026-08-19 · 5Am Partners Ii, Llc, Andrew J. SchwabSold $94,710 on 2026-09-22 · 5Am Ventures Ii Lp, Andrew J. SchwabSold $129,467 on 2026-09-16 · Andrew J. Schwab, Kush ParmarSold $228,000 on 2026-08-18 · 5Am Partners Ii, Llc, Andrew J. SchwabSold $384,400 on 2026-09-23 · 5Am Ventures Ii Lp, Andrew J. Schwab
Bought, 12 months$0
Sold, 12 months$889K
Insiders buying0
Insiders selling4

Skye Bioscience insider trading at a glance (Oct 9, 2026): in the past 12 months, 0 insiders bought $0 and 4 sold $889K of SKYE stock on the open market.

SKYE insider buying and selling by quarter

Open-market purchases (green, above the line) and sales (red, below), by trade date.

Q3 2026: $889K sold (30 trades)Q3 2026Q4 2026
QuarterBoughtPurchasesSoldSales
Q4 2026—0—0
Q3 2026—0$889K30

Valuation, profit and volume

P/E (trailing)n/aSector median —
Market value— 
Profit margin—Revenue growth —
Volume vs. 50-day0.3×Last 5 sessions
Insiders' paper profit—On all tracked purchases —

Summary

Over the past 12 months, 0 Skye Bioscience, Inc. insiders reported open-market purchases totaling $0, while 4 insiders reported sales totaling $889K. 0 of 30 recorded sales were made under pre-scheduled Rule 10b5-1 trading plans, which are usually less informative than discretionary sales.

Insider transactions

Open-market purchases and sales.

Filed Insider Type Shares Price Value Since Score
Sep 24SEC Andrew J. SchwabDirector Sell 114,851 $1.61 $185K +5.0% —
Sep 24SEC 5Am Ventures Ii Lp10% Owner Sell 114,851 $1.61 $185K +5.0% —
Sep 24SEC Andrew J. SchwabDirector Sell 27,612114,851 held (−19%) $1.65 $46K +2.4% —
Sep 24SEC 5Am Ventures Ii Lp10% Owner Sell 27,612114,851 held (−19%) $1.65 $46K +2.4% —
Sep 24SEC Andrew J. SchwabDirector Sell 4,528 $1.61 $7K +5.0% —
Sep 24SEC 5Am Ventures Ii Lp10% Owner Sell 4,528 $1.61 $7K +5.0% —
Sep 24SEC Andrew J. SchwabDirector Sell 1,0884,528 held (−19%) $1.65 $2K +2.4% —
Sep 24SEC 5Am Ventures Ii Lp10% Owner Sell 1,0884,528 held (−19%) $1.65 $2K +2.4% —
Sep 18SEC Kush Parmar10% Owner Sell 32,607142,463 held (−19%) $1.91 $62K -11.5% —
Sep 18SEC Andrew J. SchwabDirector Sell 32,607142,463 held (−19%) $1.91 $62K -11.5% —
Sep 18SEC Kush Parmar10% Owner Sell 1,2855,616 held (−19%) $1.91 $2K -11.5% —
Sep 18SEC Andrew J. SchwabDirector Sell 1,2855,616 held (−19%) $1.91 $2K -11.5% —
Aug 20SEC 5Am Partners Ii, Llc10% Owner Sell 253,0807,914,126 held (−3%) $0.38 $96K +344.7% —
Aug 20SEC Andrew J. SchwabDirector Sell 253,0807,914,126 held (−3%) $0.38 $96K +344.7% —
Aug 20SEC 5Am Partners Ii, Llc10% Owner Sell 57,4767,856,650 held (−1%) $0.35 $20K +382.9% —
Aug 20SEC Andrew J. SchwabDirector Sell 57,4767,856,650 held (−1%) $0.35 $20K +382.9% —
Aug 20SEC 5Am Partners Ii, Llc10% Owner Sell 45,0901,411,974 held (−3%) $0.38 $17K +344.7% —
Aug 20SEC Andrew J. SchwabDirector Sell 45,0901,411,974 held (−3%) $0.38 $17K +344.7% —
Aug 20SEC 5Am Partners Ii, Llc10% Owner Sell 10,2551,401,719 held (−1%) $0.35 $4K +382.9% —
Aug 20SEC Andrew J. SchwabDirector Sell 10,2551,401,719 held (−1%) $0.35 $4K +382.9% —
Aug 20SEC 5Am Partners Ii, Llc10% Owner Sell 6,4957,850,155 held (−0%) $0.32 $2K +428.1% —
Aug 20SEC Andrew J. SchwabDirector Sell 6,4957,850,155 held (−0%) $0.32 $2K +428.1% —
Aug 20SEC 5Am Partners Ii, Llc10% Owner Sell 1,83055,663 held (−3%) $0.38 $695 +344.7% —
Aug 20SEC Andrew J. SchwabDirector Sell 1,83055,663 held (−3%) $0.38 $695 +344.7% —
Aug 20SEC 5Am Partners Ii, Llc10% Owner Sell 1,1591,400,560 held (−0%) $0.32 $371 +428.1% —
Aug 20SEC Andrew J. SchwabDirector Sell 1,1591,400,560 held (−0%) $0.32 $371 +428.1% —
Aug 20SEC 5Am Partners Ii, Llc10% Owner Sell 40955,254 held (−1%) $0.35 $143 +382.9% —
Aug 20SEC Andrew J. SchwabDirector Sell 40955,254 held (−1%) $0.35 $143 +382.9% —
Aug 20SEC 5Am Partners Ii, Llc10% Owner Sell 4655,208 held (−0%) $0.32 $15 +428.1% —
Aug 20SEC Andrew J. SchwabDirector Sell 4655,208 held (−0%) $0.32 $15 +428.1% —

Insiders at Skye Bioscience, Inc.

InsiderBoughtSoldLast filingScore
Andrew J. SchwabDirector — $445K Sep 24, 2026 —
5Am Ventures Ii Lp10% Owner — $240K Sep 24, 2026 —
5Am Partners Ii, Llc10% Owner — $140K Aug 20, 2026 —
Kush Parmar10% Owner — $65K Sep 18, 2026 —

SKYE stock: common questions

Are Skye Bioscience, Inc. insiders buying SKYE stock?

In the past 12 months, 0 insiders reported open-market purchases of SKYE worth $0.

Are Skye Bioscience, Inc. insiders selling SKYE stock?

4 insiders reported sales worth $889K over the same period.

Where does this data come from?

Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.

What is SKYE's 52-week range?

Over the past year SKYE has traded between $1.57 and $13.84. It last closed at $1.69 on Oct 9, 2026.